{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:58:11Z","timestamp":1792857491906,"version":"4.5.0"},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vulval squamous cell carcinoma (VSCC) represents approximately 90% of all vulval cancers. Despite its rarity relative to other gynaecological or skin malignancies, the recent growing body of epidemiological and clinical evidence has resulted in important refinements to national guidelines. This review offers a comprehensive overview of the current evidence regarding the epidemiology, clinical features, diagnosis, and management of VSCC. There are two distinct aetiological pathways currently identified in the pathogenesis of VSCC. Human papillomavirus (HPV)-dependent VSCC is commonly found in younger people, driven by a persistent infection of high-risk HPV genotypes (most commonly HPV16). HPV-independent VSCC arises in association with chronic inflammatory dermatoses (typically lichen sclerosus) owing to mounting DNA damage by oxidative stress and lipid peroxidation. Globally, the incidence of vulval cancer has been rising. In 2020, the Global Cancer Observatory reported the highest incidence rates in Western Europe, Northern America and Northern Europe. Although VSCC commonly presents with a \u2018suspicious vulval lesion\u2019, early symptoms may be wide-ranging and nonspecific, leading to diagnostic delays. This is further compounded by the stigma and embarrassment felt when discussing vulval symptoms. Diagnostic workup involves a clinical history and examination, vulvoscopy and multiple biopsies. The mainstay of treatment involves surgical excision with or without chemoradiotherapy, immunotherapy and lymph node biopsies, dependent on the Federation of Gynaecology and Obstetrics staging and progression. The prognosis is heavily dependent on stage. In England, 5-year crude net survival of early-stage VSCC (stage 1\u20132) is 78.2%, but it falls to 33.1% at later stages (stage 3\u20134). This is significantly poorer than cutaneous squamous cell carcinomas elsewhere. The advent of the HPV vaccine may be the first significant medical intervention to have an impact on VSCC incidence in decades.<\/jats:p>","DOI":"10.1093\/ced\/llaf389","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T11:33:07Z","timestamp":1755603187000},"page":"1-13","source":"Crossref","is-referenced-by-count":7,"title":["Vulval squamous cell carcinoma: a review"],"prefix":"10.1093","volume":"51","author":[{"given":"Charlotte","family":"Sheern","sequence":"first","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick J","family":"Levell","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich ,","place":["UK"]},{"name":"Department of Dermatology, Norfolk and Norwich University Hospital , Norwich ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J","family":"Craig","sequence":"additional","affiliation":[{"name":"Cellular Pathology, North Bristol NHS Trust, Southmead Hospital , Bristol ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A","family":"Harwood","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Barts Health NHS Trust , London ,","place":["UK"]},{"name":"Centre for Cell Biology and Cutaneous Research, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly","family":"Jeffrey","sequence":"additional","affiliation":[{"name":"National Disease Registration Service, NHS Digital , Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Nordin","sequence":"additional","affiliation":[{"name":"East Kent Gynaecological Oncology Centre, East Kent Hospitals University Foundation NHS Trust , Kent ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Norfolk and Norwich University Hospital , Norwich ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C","family":"Sterling","sequence":"additional","affiliation":[{"name":"Cambridge University Hospitals NHS Foundation Trust , Cambridge ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe C","family":"Venables","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich ,","place":["UK"]},{"name":"Department of Dermatology, Norfolk and Norwich University Hospital , Norwich ,","place":["UK"]},{"name":"National Disease Registration Service, NHS Digital , Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"2025122312174561000_llaf389-B1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejogrb.2023.11.013","article-title":"British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: an update on recommendations for practice 2023","volume":"292","author":"Morrison","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025122312174561000_llaf389-B2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/ijgc-2023-004486","article-title":"European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer \u2013 Update 2023","volume":"33","author":"Oonk","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"2025122312174561000_llaf389-B3","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1158\/1055-9965.EPI-16-0019","article-title":"Lichen sclerosus: incidence and risk of vulvar squamous cell carcinoma","volume":"25","author":"Bleeker","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025122312174561000_llaf389-B4","article-title":"Detailed Statistics from the Get Data Out programme","author":"National Disease Registration Service","year":"2020","journal-title":"Skin tumours"},{"key":"2025122312174561000_llaf389-B5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/1471-0528.12459","article-title":"Vulval cancer incidence, mortality and survival in England: age-related trends","volume":"121","author":"Lai","year":"2014","journal-title":"BJOG"},{"key":"2025122312174561000_llaf389-B6","author":"Cancer Research UK"},{"key":"2025122312174561000_llaf389-B7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/LGT.0b013e3182472947","article-title":"Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction","volume":"16","author":"Gargano","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"2025122312174561000_llaf389-B8","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jadohealth.2010.01.016","article-title":"Beyond cervical cancer: burden of other HPV-related cancers among men and women","volume":"46","author":"Chaturvedi","year":"2010","journal-title":"J Adolesc Health"},{"key":"2025122312174561000_llaf389-B9","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/ijc.30821","article-title":"Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva","volume":"141","author":"Faber","year":"2017","journal-title":"Int J Cancer"},{"key":"2025122312174561000_llaf389-B10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1470-2045(23)00066-9","article-title":"Prevalence of human papillomavirus DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia: a systematic review and meta-analysis","volume":"24","author":"Zhuang","year":"2023","journal-title":"Lancet Oncol"},{"key":"2025122312174561000_llaf389-B11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/OLQ.0000000000001356","article-title":"Estimated prevalence and incidence of disease-associated HPV types among 15\u201359-year-olds in the United States","volume":"48","author":"Lewis","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2025122312174561000_llaf389-B12","author":"Cancer Research UK"},{"key":"2025122312174561000_llaf389-B13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ygyno.2020.03.013","article-title":"Incidence trends of vulvar squamous cell carcinoma in Italy from 1990 to 2015","volume":"157","author":"Mancini","year":"2020","journal-title":"Gynecol Oncol"},{"key":"2025122312174561000_llaf389-B14","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1016\/j.ejca.2013.08.003","article-title":"Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma","volume":"49","author":"Schuurman","year":"2013","journal-title":"Eur J Cancer"},{"key":"2025122312174561000_llaf389-B15","author":"International Agency for Research on Cancer"},{"key":"2025122312174561000_llaf389-B16","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/ijc.34655","article-title":"Global incidence, risk factors and trends of vulvar cancer: a country-based analysis of cancer registries","volume":"153","author":"Huang","year":"2023","journal-title":"Int J Cancer"},{"key":"2025122312174561000_llaf389-B17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ijgo.12818","article-title":"Relationship between vulvar symptoms and incidence of vulvar cancer in women referred to a rapid access clinic","volume":"145","author":"Wiggans","year":"2019","journal-title":"Int J Gynecol Obstet"},{"key":"2025122312174561000_llaf389-B18","doi-asserted-by":"crossref","first-page":"8725","DOI":"10.18632\/oncotarget.23848","article-title":"Potential delay in the diagnosis of vulvar cancer and associated risk factors in women treated in German gynecological practices","volume":"9","author":"Muigai","year":"2018","journal-title":"Oncotarget"},{"key":"2025122312174561000_llaf389-B19","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1067\/S0002-9378(03)00792-0","article-title":"Vulvar squamous cell carcinoma: guidelines for early diagnosis and treatment","volume":"189","author":"Tyring","year":"2003","journal-title":"Am J Obstet Gynaecol"},{"key":"2025122312174561000_llaf389-B20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/IJWH.S68979","article-title":"Vulvar cancer: epidemiology, clinical presentation, and management options","volume":"20","author":"Alkatout","year":"2015","journal-title":"Int J Womens Health"},{"key":"2025122312174561000_llaf389-B21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1525-1438.1999.99016.x","article-title":"Does lichen sclerosus play a central role in the pathogenesis of human papillomavirus negative vulvar squamous cell carcinoma? The itch-scratch-lichen sclerosus hypothesis","volume":"9","author":"Scurry","year":"1999","journal-title":"Int J Gynecol Cancer"},{"key":"2025122312174561000_llaf389-B22","author":"Bosse"},{"key":"2025122312174561000_llaf389-B23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PAP.0000000000000155","article-title":"Role of human papillomavirus in vulvar cancer","volume":"24","author":"Rakislova","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"2025122312174561000_llaf389-B24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41417-023-00682-3","article-title":"HPV E6\/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor","volume":"31","author":"Peng","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"2025122312174561000_llaf389-B25","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1136\/ijgc-2022-003616","article-title":"HPV-independent and HPV-associated vulvar squamous cell carcinoma: two different cancers","volume":"32","author":"Eva","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"2025122312174561000_llaf389-B26","author":"Gallego"},{"key":"2025122312174561000_llaf389-B27","first-page":"CD013479","article-title":"Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males","volume":"11","author":"Bergman","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2025122312174561000_llaf389-B28","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"2025122312174561000_llaf389-B29","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archderm.140.6.702","article-title":"Does treatment of vulvar lichen sclerosus influence its prognosis?","volume":"140","author":"Cooper","year":"2004","journal-title":"Arch Dermatol"},{"key":"2025122312174561000_llaf389-B30","first-page":"223","article-title":"Lichen sclerosus: the role of oxidative stress in the pathogenesis of the disease and its possible transformation into carcinoma","volume":"11","author":"Paulis","year":"2019","journal-title":"Res Rep Urol"},{"key":"2025122312174561000_llaf389-B31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/his.14860","article-title":"Vulvar squamous cell carcinoma arising on human papillomavirus-independent precursors mimicking high-grade squamous intra-epithelial lesion: a distinct and highly recurrent subtype of vulvar cancer","volume":"82","author":"Carreras-Dieguez","year":"2023","journal-title":"Histopathology"},{"key":"2025122312174561000_llaf389-B32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13045-020-00986-z","article-title":"Immunosenescence: a key player in cancer development","volume":"13","author":"Lian","year":"2020","journal-title":"J Haematol Oncol"},{"key":"2025122312174561000_llaf389-B33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.humpath.2022.05.009","article-title":"Tumor budding activity is an independent prognostic factor in squamous cell carcinoma of the vulva","volume":"126","author":"Zare","year":"2022","journal-title":"Hum Pathol"},{"key":"2025122312174561000_llaf389-B34","doi-asserted-by":"crossref","DOI":"10.1002\/9781119146087","volume-title":"A Practical Guide to Vulval Disease: Diagnosis and Management","author":"Lewis","year":"2017"},{"key":"2025122312174561000_llaf389-B35","author":"Capria"},{"key":"2025122312174561000_llaf389-B36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.16241","article-title":"British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018","volume":"178","author":"Lewis","year":"2018","journal-title":"Br J Dermatol"},{"key":"2025122312174561000_llaf389-B37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/01443610701251539","article-title":"Long-term follow-up of patients with lichen sclerosus: does it really happen?","volume":"27","author":"Balasubramaniam","year":"2007","journal-title":"J Obstet Gynaecol"},{"key":"2025122312174561000_llaf389-B38","author":"Cancer Research UK"},{"key":"2025122312174561000_llaf389-B39","first-page":"67","article-title":"Surgical staging of invasive squamous cell carcinoma of the vulva.\u00a0Analysis of treatment and survival","volume":"81","author":"Origoni","year":"1996","journal-title":"Int Surg"},{"key":"2025122312174561000_llaf389-B40","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1470-2045(22)00127-9","article-title":"Risk factors and prognostic implications of diagnosis of cancer within 30\u2005days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study","volume":"23","author":"McPhail","year":"2022","journal-title":"Lancet Oncol"},{"key":"2025122312174561000_llaf389-B41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/LGT.0000000000000585","article-title":"Knowledge of vulvar anatomy and self-examination in a sample of Italian women","volume":"25","author":"Preti","year":"2021","journal-title":"J Low Genit Tract Dis"},{"key":"2025122312174561000_llaf389-B42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/LGT.0000000000000848","article-title":"The barriers and perceived benefits to vulvar self-examination in the management of vulvar lichen sclerosus","volume":"29","author":"Adamson","year":"2025","journal-title":"J Low Genit Tract Dis"},{"key":"2025122312174561000_llaf389-B43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ijgo.13880","article-title":"FIGO staging for carcinoma of the vulva: 2021 revision","volume":"155","author":"Olawaiye","year":"2021","journal-title":"Int J Gynecol Obstet"},{"key":"2025122312174561000_llaf389-B44"},{"key":"2025122312174561000_llaf389-B45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejca.2016.07.006","article-title":"Tumour-free margins in vulvar squamous cell carcinoma: does distance really matter?","volume":"65","author":"Nooij","year":"2016","journal-title":"Eur J Cancer"},{"key":"2025122312174561000_llaf389-B46","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.3390\/cancers13164061","article-title":"Role of chemotherapy in vulvar cancers: time to rethink standard of care?","volume":"13","author":"Mazzotta","year":"2021","journal-title":"Cancers (Basil)"},{"key":"2025122312174561000_llaf389-B47","doi-asserted-by":"crossref","first-page":"1352975","DOI":"10.3389\/fonc.2024.1352975","article-title":"Efficacy of pembrolizumab in advanced cancer of the vulva: a systematic review and single-arm meta-analysis","volume":"14","author":"Schwab","year":"2024","journal-title":"Front Oncol"},{"key":"2025122312174561000_llaf389-B48","author":"US Food and Drug Administration"},{"key":"2025122312174561000_llaf389-B49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jpra.2022.06.003","article-title":"Cemiplimab and cutaneous squamous cell carcinoma: from bench to bedside","volume":"33","author":"Goodman","year":"2022","journal-title":"JPRAS Open"},{"key":"2025122312174561000_llaf389-B50","first-page":"1269","article-title":"Vulvar cancer","volume":"66","author":"Canavan","year":"2002","journal-title":"Am Fam Physician"},{"key":"2025122312174561000_llaf389-B51","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ygyno.2005.03.006","article-title":"Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva","volume":"97","author":"Gonzalez Bosquet","year":"2005","journal-title":"Gynecol Oncol"},{"key":"2025122312174561000_llaf389-B52","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jaad.2023.03.049","article-title":"Defining and quantifying histopathologic risk factors for regional and distant metastases in a large cohort of vulvar squamous cell carcinomas","volume":"89","author":"Cheraghlou","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"2025122312174561000_llaf389-B53","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/ijgc-2019-000526","article-title":"Prognostic factors in patients with vulvar cancer: the VULCAN study","volume":"30","author":"Zapardiel","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"2025122312174561000_llaf389-B54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcrpr.2018.06.003","article-title":"Survival and prognosis factors of lymphadenectomy in vulvar carcinoma: a Tunisian single center study about 150 cases","volume":"5","author":"Gadria","year":"2018","journal-title":"J Cancer Res Pract"},{"key":"2025122312174561000_llaf389-B55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0090-8258(92)90068-T","article-title":"Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva","volume":"47","author":"Russell","year":"1992","journal-title":"Gynecol Oncol"},{"key":"2025122312174561000_llaf389-B56","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0360-3016(93)90496-I","article-title":"Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer","volume":"26","author":"Koh","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025122312174561000_llaf389-B57","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1525-1438.1994.04030150.x","article-title":"Treatment of advanced carcinoma of the vulva with chemoradiotherapy\u2014can exenterative surgery be avoided?","volume":"4","author":"Sebag-Montefiore","year":"1994","journal-title":"Int J Gynecol Cancer"},{"key":"2025122312174561000_llaf389-B58","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/1097-0142(19950501)75:9<2289::AID-CNCR2820750917>3.0.CO;2-4","article-title":"Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva","volume":"75","author":"Wahlen","year":"1995","journal-title":"Cancer"},{"key":"2025122312174561000_llaf389-B59","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/gyno.1997.4758","article-title":"Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva","volume":"66","author":"Cunningham","year":"1997","journal-title":"Gynecol Oncol"},{"key":"2025122312174561000_llaf389-B60","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0360-3016(00)00593-9","article-title":"Preliminary results of chemoradiation as a primary treatment for vulvar carcinoma","volume":"48","author":"Akl","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025122312174561000_llaf389-B61","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ygyno.2004.03.019","article-title":"Chemoradiation with 5-fluorouracil and mitomycin C in the treatment of vulvar squamous cell carcinoma","volume":"93","author":"Mulayim","year":"2004","journal-title":"Gynecol Oncol"},{"key":"2025122312174561000_llaf389-B62","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ygyno.2007.11.010","article-title":"Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation","volume":"108","author":"Landrum","year":"2008","journal-title":"Gynecol Oncol"},{"key":"2025122312174561000_llaf389-B63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ygyno.2010.09.004","article-title":"Outcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every-3\u20134-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulva","volume":"120","author":"Mak","year":"2011","journal-title":"Gynecol Oncol"},{"key":"2025122312174561000_llaf389-B64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/COC.0b013e3181cae6a1","article-title":"The role of chemo-radiotherapy in the management of locally advanced carcinoma of the vulva: single institutional experience and review of literature","volume":"34","author":"Tans","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"2025122312174561000_llaf389-B65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-8258(89)90157-1","article-title":"Concurrent radiation and chemotherapy in vulvar carcinoma","volume":"34","author":"Thomas","year":"1989","journal-title":"Gynecol Oncol"},{"key":"2025122312174561000_llaf389-B66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0090-8258(91)90345-6","article-title":"Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva","volume":"42","author":"Berek","year":"1991","journal-title":"Gynecol Oncol"},{"key":"2025122312174561000_llaf389-B67","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/gyno.1995.1267","article-title":"Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva","volume":"59","author":"Eifel","year":"1995","journal-title":"Gynecol Oncol"},{"key":"2025122312174561000_llaf389-B68","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3109\/02841869309092448","article-title":"Combined bleomycin and irradiation in preoperative treatment of advanced squamous cell carcinoma of the vulva","volume":"32","author":"Scheistr\u00f6en","year":"1993","journal-title":"Acta Oncol"},{"key":"2025122312174561000_llaf389-B69","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/gyno.1996.0150","article-title":"Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma","volume":"61","author":"Landoni","year":"1996","journal-title":"Gynecol Oncol"},{"key":"2025122312174561000_llaf389-B70","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1472::AID-CNCR8>3.0.CO;2-E","article-title":"Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma: a pilot study","volume":"77","author":"Lupi","year":"1996","journal-title":"Cancer"},{"key":"2025122312174561000_llaf389-B71","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/gyno.1997.4804","article-title":"Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer","volume":"66","author":"Leiserowitz","year":"1997","journal-title":"Gynecol Oncol"},{"key":"2025122312174561000_llaf389-B72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(98)00193-X","article-title":"Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the gynecologic oncology group","volume":"42","author":"Moore","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025122312174561000_llaf389-B73","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0360-3016(00)00762-8","article-title":"Preoperative chemo-radiation for carcinoma of the vulva with N2\/N3 nodes: a gynecologic oncology group study","volume":"48","author":"Montana","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025122312174561000_llaf389-B74","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0360-3016(00)00569-1","article-title":"Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva","volume":"47","author":"Han","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025122312174561000_llaf389-B75","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ygyno.2005.07.126","article-title":"Preoperative chemoradiation for locally advanced carcinoma of the vulva","volume":"99","author":"Gerszten","year":"2005","journal-title":"Gynecol Oncol"},{"key":"2025122312174561000_llaf389-B76","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2011.11.003","article-title":"A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study","volume":"124","author":"Moore","year":"2012","journal-title":"Gynecol Oncol"},{"key":"2025122312174561000_llaf389-B77","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ijrobp.2012.11.012","article-title":"Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse","volume":"85","author":"Beriwal","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025122312174561000_llaf389-B78","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.ijrobp.2012.03.030","article-title":"Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy","volume":"84","author":"Damast","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf389\/64096498\/llaf389.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/1\/1\/64096498\/llaf389.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/1\/1\/64096498\/llaf389.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:17:59Z","timestamp":1766510279000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/1\/1\/8238794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,8,20]]},"published-print":{"date-parts":[[2025,12,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf389","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,8,20]]}}}